Reperfusion activates metalloproteinases that contribute to neurovascular injury
Aigang Lu1, Joseph F Clark, Joseph P Broderick
1Department of Neurology, University of Cincinnati, Cincinnati, OH 45267-0532, USA.lua@ucmail.uc.edu
Abstract:
In this study, we examine the effects of reperfusion on the activation of matrix metalloproteinase (MMP) and assess the relationship between MMP activation during reperfusion and neurovascular injury. Ischemia was produced using suture-induced middle cerebral artery occlusion in rats. The MMP activation was examined with in situ and gel zymography. Injury to cerebral endothelial cells and basal lamina was assessed using endothelial barrier antigen (EBA) and collagen IV immunohistochemistry. Injury to neurons and glial cells was assessed using Cresyl violet staining. These were examined at 3 h after reperfusion (8 h after initiation of ischemia) and compared with permanent ischemia at the same time points to assess the effects of reperfusion. A broad-spectrum MMP inhibitor, AHA (p-aminobenzoyl-Gly-Pro-D-Leu-D-Ala-hydroxamate, 50 mg/kg intravenously) was administered 30 min before reperfusion to assess the roles of MMPs in activating gelatinolytic enzymes and in reperfusion-induced injury. We found that reperfusion accelerated and potentiated MMP-9 and MMP-2 activation and injury to EBA and collagen IV immunopositive microvasculature and to neurons and glial cells in ischemic cortex and striatum relative to permanent ischemia. Administering AHA 30 min before reperfusion decreased MMP-9 activation and neurovascular injury in ischemic cerebral cortex.
Insights
Reperfusion after stroke potentiates matrix metalloproteinase (MMP) activation, increasing neurovascular injury. Inhibiting MMPs before reperfusion significantly reduced this damage, highlighting MMPs as therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Matrix metalloproteinases (MMPs) play a role in tissue remodeling and injury.
- Understanding the role of MMPs during the reperfusion phase of ischemic stroke is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the effect of reperfusion on matrix metalloproteinase (MMP) activation.
- To determine the relationship between MMP activation during reperfusion and the extent of neurovascular injury.
- To evaluate the therapeutic potential of MMP inhibitors in mitigating reperfusion-induced brain damage.
Main Methods:
- Middle cerebral artery occlusion (MCAO) model in rats to induce ischemia.
- In situ and gel zymography to assess MMP activation.
- Immunohistochemistry (EBA, collagen IV) and Cresyl violet staining to evaluate neurovascular and cellular injury.
- Administration of a broad-spectrum MMP inhibitor (AHA) prior to reperfusion.
Main Results:
- Reperfusion significantly accelerated and potentiated the activation of MMP-9 and MMP-2 compared to permanent ischemia.
- Reperfusion led to increased injury of cerebral endothelial cells, basal lamina, neurons, and glial cells.
- Administration of AHA before reperfusion reduced MMP-9 activation and subsequent neurovascular injury in the ischemic cerebral cortex.
Conclusions:
- Reperfusion exacerbates neurovascular injury following ischemic stroke, partly through enhanced MMP activation.
- Targeting MMPs with inhibitors like AHA before reperfusion shows promise in protecting the brain from ischemic damage.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Vascular Spasm
Neurogenesis and Regeneration of Nervous Tissue
Clot Retraction and Fibrinolysis
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...

